GeneDx Holdings Corp. logo WGS - GeneDx Holdings Corp.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $87.43 DETAILS
HIGH: $150.00
LOW: $63.00
MEDIAN: $75.00
CONSENSUS: $87.43
UPSIDE: 33.20%

About GeneDx Holdings Corp. (http://www.genedx.com)

GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.

Key Executives

NAME TITLE DOB SALARY
Katherine A. Stueland Chief Executive Officer & Director 1976 $1,808,619 USD
Kevin Feeley Chief Financial Officer 1981 $932,000 USD
Bryan Dechairo Chief Operating Officer 1973 $882,404 USD
Heidi C. Chen Chief Legal Officer 1967
Jami Biliboaca Chief People Officer
Linda Genen Chief Medical Officer
Lisa Gurry Chief Business Officer
Mark A. Gardner President 1966
Martin G. Reese President of Fabric Genomics
Melanie Duquette Chief Growth Officer
Sabrina Dunbar Director of Investor Relations & Communications

Company Peers

Peer analysis pending, check back in 1-2 minutes.